Sur Le Chemin ASBL
0.7 FTESur Le Chemin reported revenue of 64,705 € for the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026), with 0.7 full-time equivalent.
The score of Sur Le Chemin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sur Le Chemin's annual accounts
| 2025 | |
|---|---|
| Revenue | 64,705 € |
| Net result | 9,498 € |
| Equity | 27,670 € |
| Cash | 17,846 € |
| EBITDA | 10,472 € |
| Total assets | 31,180 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
Sur Le Chemin's financial analysis
- Solvency88.7%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sur Le Chemin
Sur Le Chemin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0704.890.189
- VAT number
- BE0704890189
- Peppol
- Registered · 0208:0704890189 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 21 Sep 2018
- Registered office
- 1460 Ittre
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
Sur Le Chemin (ASBL) has been based in Ittre since 2018, active in: general medical practice activities. For 2025, it reports revenue of 64,705 €, a net profit of 9,498 € and equity of 27,670 €. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 88.7%, above the median of its sector (65.8%).
Companies similar to Sur Le Chemin
Companies in the same business, of comparable size and area, outside its group.
- Maison Médicale Du Centre General medical practice activities Seneffe · balance sheet 92,182 €
- Belgian Football Doctors & Associates General medical practice activities Ternat · balance sheet 25,546 €
- Médecine Pour Le Peuple - La Louvière General medical practice activities La Louvière · balance sheet 667,600 €
- Postes de Garde Fédération des Médecins Généralistes du Centre et de Binche General medical practice activities La Louvière · balance sheet 288,227 €
- Secho KDV General medical practice activities Moorslede · balance sheet 4,376 €
- Centre Medical DE Jemeppe General medical practice activities Seraing · balance sheet 150,002 €
- Centre Benenzon Belgique Activities of psychologists and psychotherapists, except medical doctors Schaerbeek · balance sheet 230,230 €
- GVHV Lommel General medical practice activities Lommel · balance sheet 303,369 €
Frequently asked questions about Sur Le Chemin
What is the revenue of Sur Le Chemin?
According to the 2025 annual accounts filed with the NBB, the revenue of Sur Le Chemin amounts to 64,705 €.
What is the VAT number of Sur Le Chemin?
In Belgium, the VAT number is the company number prefixed with BE: BE0704890189 for Sur Le Chemin, if the company is VAT-registered. Its company number (CBE) is 0704.890.189.
Where is the registered office of Sur Le Chemin?
According to the CBE register, the registered office of Sur Le Chemin is in 1460 Ittre.
What is the equity of Sur Le Chemin?
At the close of the 2025 financial year, the equity of Sur Le Chemin amounts to 27,670 €, a solvency of 88.7% of total assets.
How many people work at Sur Le Chemin?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sur Le Chemin?
The register lists 3 active mandates at Sur Le Chemin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sur Le Chemin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →